85 related articles for article (PubMed ID: 6197166)
1. Hairy cell leukemia responsive to chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD).
Patten E; Gill DP; Weiss GB
Cancer Treat Rep; 1983 Dec; 67(12):1147-8. PubMed ID: 6197166
[No Abstract] [Full Text] [Related]
2. [Is the ABVD an optimal regimen for Hodgkins disease?].
Nakamura S
Rinsho Ketsueki; 1998 Feb; 39(2):109-10. PubMed ID: 9545813
[No Abstract] [Full Text] [Related]
3. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M;
J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458
[TBL] [Abstract][Full Text] [Related]
4. Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Oliveira JS
Ann Hematol; 2009 Jul; 88(7):633-7. PubMed ID: 18998131
[TBL] [Abstract][Full Text] [Related]
5. ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma.
Ferrario A; Radaelli F; Goldaniga M; F FG; Olivero B; Rossi F; Baldini L
Leuk Res; 2010 Oct; 34(10):e280-1. PubMed ID: 20605208
[No Abstract] [Full Text] [Related]
6. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
Constine LS
J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
[No Abstract] [Full Text] [Related]
7. Cutaneous flagellate pigmentation by bleomycin.
Spedini P; Bergonzi C; Morandi S
Haematologica; 2000 Aug; 85(8):870. PubMed ID: 10942936
[No Abstract] [Full Text] [Related]
8. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
9. [Chronic lymphatic leukemia and Hodgkin's disease].
Calvo Villas J; Ramírez Sánchez M; Sicilia Guillén F
Sangre (Barc); 1999 Oct; 44(5):393-4. PubMed ID: 10618924
[No Abstract] [Full Text] [Related]
10. Axillary swelling and a reduced general condition in a middle-aged man.
Klimm B; Engert A; Diehl V;
Nat Clin Pract Oncol; 2004 Nov; 1(1):51-4; quiz 1 p following 54. PubMed ID: 16264800
[TBL] [Abstract][Full Text] [Related]
11. [A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
Ziółko E
Pol Merkur Lekarski; 1997 Jul; 3(13):8-9. PubMed ID: 9432303
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
Lipton JH; Gospodarowicz M; Reingold S
Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
Younes A; Fayad L; Romaguera J; Pro B; Goy A; Wang M
Eur J Cancer; 2006 Nov; 42(17):2976-81. PubMed ID: 17008093
[TBL] [Abstract][Full Text] [Related]
14. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
Kharchenko VP; Datsenko PV; Panyshin GA; Sotnikov VM; Mel'nik IuD
Vopr Onkol; 2006; 52(5):531-7. PubMed ID: 17168361
[TBL] [Abstract][Full Text] [Related]
15. [The whole dose at once?].
Rodríguez García J; Ramos Ortega FJ; Sandoval Guerra V; García Sanz R
Sangre (Barc); 1996 Jun; 41(3):259. PubMed ID: 8755216
[No Abstract] [Full Text] [Related]
16. What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
Hehn ST; Miller TP
Curr Hematol Rep; 2004 Jan; 3(1):17-26. PubMed ID: 14695845
[TBL] [Abstract][Full Text] [Related]
17. Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
Shimamoto T; Hayashi S; Ando K; Yguchi M; Miyazawa K; Kimura Y; Mukai K; Serizawa H; Ohyashiki K
Am J Hematol; 2001 Jan; 66(1):49-52. PubMed ID: 11426493
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin lymphoma with cutaneous involvement.
Hsia CC; Howson-Jan K; Rizkalla KS
Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy and Hodgkin's lymphoma.
Das P; Ha CS; Cox JD
J Clin Oncol; 2005 Dec; 23(34):8914; author reply 8914-6. PubMed ID: 16314655
[No Abstract] [Full Text] [Related]
20. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
Pivnik AV; Rastrigin NA; Moiseeva TN; Lutsenko IN; Dudarova RG; Shavlokhov VS; Efimov IV; Kozhurin SV; Shitareva IV; Gemdzhian EG; Tsyba NN; Kolosova LIu; Melikian AL; Skidan NI; Pan'shin GA; Sotnikov VM; Dotsenko PV; Nechistiuk AV
Ter Arkh; 2006; 78(8):57-62. PubMed ID: 17078219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
